期刊文献+

H1N1流感病毒在微载体培养MDCK细胞上增殖的研究 被引量:12

Research on multiplication of the H1N1 subtype influenza virus in large-scale micro-carrier-based MDCK cell culture system
下载PDF
导出
摘要 目的探索MDCK细胞在微载体上的培养条件,并研究H1N1型流感病毒在MDCK细胞上的增殖条件。方法在微载体上培养好MDCK细胞上用H1N1型流感病毒在不同的病毒感染复数(MOI)、胰酶浓度两个关键的病毒增殖条件进行流感病毒在细胞上的增殖研究。结果微载体质量浓度为6 g/L时,MDCK细胞培养密度可以达到4.5×106cells/mL。在MOI为0.05接种流感病毒,胰酶质量浓度4μg/mL,流感病毒在MDCK细胞上可获得较高的滴度。结论 MDCK细胞用微载体培养可以达到较高的细胞密度,可以作为规模化生产新型流感病毒疫苗的主要细胞基质进行进一步的研究。 Objective To investigate the growth kinetics of influenza virus subtype H1N1 in mammalian cell-based microcarrier culture system, and then optimize cultural conditions. Methods On the basis of diversity of MOI and TPCK-trypsin concentration and micro-cartier concentration, MDCK cells cultured in micro-carrier was infected by influenza virus. The density of MDCK cells and HA concentration were detected. Results At of 0.05 MOI and 4 μg/mL of TPCK-trypsin concentration, MDCK cell density was 4.5 ×106 cells/mL and HA concentration was higher with the concentration of microcarrier 6 g/L. Conclusion The results demonstrated that the influenza virus H1 N1 subtype could be grown in large-scale mammalian cell-based micro-carrier culture system with high-yield virus and evidenced the feasibility of mammalian cellbased micro-carrier culture system for influenza vaccine.
出处 《微生物学免疫学进展》 2013年第1期12-15,共4页 Progress In Microbiology and Immunology
基金 国家863科技计划项目(2010AA022905) 甘肃省科技重大专项(1002FKDA049)
关键词 H1N1流感病毒 犬肾传代细胞 微载体 病毒感染复数 浓度 H1N1 influenza virus MDCK cell Micro-carrier Muhiplicity of infection( MOI) Concentration
  • 相关文献

参考文献9

  • 1Mori K, Maeda M. Surgical treatment of chronic subdurhematoma in500 consecutive cases: clinical charaeteristics, surgical outcome,complications,and recurrence rate[ J] . Neurol Med Chir,2001 ,41(8):371-381.
  • 2吴俊东,朱凤才.流感疫苗研究的进展[J].江苏预防医学,2008,19(2):83-85. 被引量:16
  • 3Cell culture as a substrate for the production of influenza vaccines:memorandum from WHO meeting [ R]. Bull World Health Organ,1995,73 ( 4) :431-435.
  • 4Montagnono B,Vincent- Falquet JC,Fanget B,et al. Thousand literscale microcarrier culture of Vero cells for killed polio virus vac-cine [J]. Dev Biol Stand, 1983 ’55 :37-42.
  • 5Merten OW. Hannoun C,Manuguerra JC,et al. Production of in-fluenza virus in cell cultures for vaccine preparation[ J] . Adv ExpMed Biol,1996,397 :141-151.
  • 6郭元吉,程小雯.流行性感冒病毒及其实验技术[M ].北京:三峡出版社,1997:100-102.
  • 7赵斌秀,李炎,何维英,高荣梅,沈瑾,李新武.流感病毒对两种细胞敏感性的比较[J].中国消毒学杂志,2008,25(5):463-465. 被引量:17
  • 8Genzel Y, Behrendt I,konig S,et al. Metabolism of MDCK cellsduring cell growth and influenza virus production in large scale mi-crocarrier culuture[ J]. Vaccine,2004,22( 17-18) :2202-2208.
  • 9Clark JM, Hirtenstein MD. Optimizing culture conditioned for theproduction of animal cells in microcarrier culture [ J ] Ann NYAcad Sci,1981,369:33-46.

二级参考文献15

  • 1张捷,汪翠玲,钮泽春,潘南胜,段凯,郜金荣.流感病毒在Vero细胞上的增殖[J].氨基酸和生物资源,2004,26(4):56-58. 被引量:4
  • 2吴少慧,舒跃龙.Vero细胞流感疫苗应用前景[J].病毒学报,2006,22(1):70-73. 被引量:6
  • 3戚凤春,汪春义,张雪梅,王亚军,李晓波,贾媛,赵大鹏,盛军.两种细胞培养流感病毒的滴度比较[J].中国生物制品学杂志,2006,19(3):291-292. 被引量:23
  • 4刘华雷,王志亮,周滨,陈溥言.血凝素蛋白裂解位点对H5亚型禽流感病毒侵入细胞的影响[J].中国预防医学杂志,2006,7(5):369-373. 被引量:3
  • 5Suarez DL, Perdue ML, Cox N, et al. Comparisons of highly vir ulent H5N1 influenza A viruses isolated form humans and chickens from HongKong[J]. J Virok, 1998, 72 (8) : 6 678-6 688.
  • 6Guo YJ, Krauss S, Senne DA, et al. Characterization of the pathogenidty of members of the newly established H9N2 influenza vires lineages in Asia[J]. Virology, 2000, 267(2): 279- 288.
  • 7Gambaryan AS, Robertson JS. Matrisivich MNl Effects of egg - adap2 ration on the receptor binding properties of human influenza, a A and B viruses[J]. Virology, 1999, 258(2): 232- 239.
  • 8de Jong JC, Beyer WE, Palache AM. et al. Mismatch between the 1997/1998 influenza vaccine = induced antibody response to this strain in the elderly[J]. J Med Virol, 2000, 61 (1): 94-99.
  • 9Lankey DL., Treanor J J, Betts RF, et al. Recombinant baculovirus in 2 fluenza A hemagglutinin vaccines are well tolerated and immuno genie inhealthy adults[J]. J Infect Dis, 1996, 174 (4): 838-841.
  • 10Treater J J, Kotkogg K, Betts RF, et al. Evaluation of tfivalent, live, cole-adapted(CAW-T) and inactivated (TIV) in2 fluenza vac cines in prevention of vires infection and illness following challenge of aeulta with wild-type influenza A (H1N1), A(H3N2), and B virusesl[J]. Vaccine, 1999, 18(9): 899-906.

共引文献30

同被引文献110

引证文献12

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部